DAPSONE (dapsone) by Viatris (2) is 12. Approved for sulfone [epc]. First approved in 2023.
Drug data last refreshed 20h ago
12.1 Mechanism of Action The mechanism of action of dapsone gel in treating acne vulgaris is not known. 12.3 Pharmacokinetics An open-label study compared the pharmacokinetics of dapsone after dapsone gel, 5%, (110 ± 60 mg/day) was applied twice daily (~BSA 22.5%) for 14 days (n=18) with a single…
Sulfone
Worked on DAPSONE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris